Eli Lilly and Company (LLY)

[Boing x 2]

New PR on Alzheimers drug for LLY

For educational purposes:

"https://www.otcdynamics.com/lly-lillys-donanemab-slowed-alzheimers-disease-progression-in-phase-2-trial-full-data-presented-at-ad-pd-2021-and-published-in-nejm/";

Sounds positive to me. I note Yahoo Finance does an article and said no improvement on secondary end points. That does not sound right to me. They are talking about 20 to 40 percent improvement in secondary end points. That is still major with a disease that is so devastating. It might also improve with more study IMHO.

Another detailed PR.

"https://flashalert.me/?symbol=LLY&source=PR&referer=https://stocktwits.com/&url=https://www.prnewswire.com:443/news-releases/lillys-donanemab-slowed-alzheimers-disease-progression-in-phase-2-trial-full-data-presented-at-adpd-2021-and-published-in-nejm-301246745.html&s3=LLY/2021-03-13/06-36-06_000000/pr/d11c6c228fcdee2eeac476a5b679a2eb/lillys-donanemab-slowed-alzheimers-disease-progression-in-phase-2-trial-full-data-presented-at-adpd-2021-and-published-in-nejm-301246745.html";

Should get more information on the Monday cc.

Boing X 2